<SEC-DOCUMENT>0001123292-18-000974-index.html : 20180928 <SEC-HEADER>0001123292-18-000974.hdr.sgml : 20180928 <ACCEPTANCE-DATETIME>20180928163302 ACCESSION NUMBER: 0001123292-18-000974 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 4 FILED AS OF DATE: 20180928 DATE AS OF CHANGE: 20180928 GROUP MEMBERS: NOVARTIS AG SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Cellular Biomedicine Group, Inc. CENTRAL INDEX KEY: 0001378624 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 861032927 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-82437 FILM NUMBER: 181094561 BUSINESS ADDRESS: STREET 1: 19925 STEVENS CREEK BLVD., SUITE 100 CITY: CUPERTINO STATE: CA ZIP: 95014 BUSINESS PHONE: (408) 973-7884 MAIL ADDRESS: STREET 1: 19925 STEVENS CREEK BLVD., SUITE 100 CITY: CUPERTINO STATE: CA ZIP: 95014 FORMER COMPANY: FORMER CONFORMED NAME: EastBridge Investment Group Corp DATE OF NAME CHANGE: 20061019 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: NOVARTIS PHARMA AG CENTRAL INDEX KEY: 0001030617 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: LICHTSTRASSE 35 STREET 2: CH-4002 CITY: BASEL STATE: V8 BUSINESS PHONE: 212-830-2474 MAIL ADDRESS: STREET 1: LICHTSTRASSE 35 STREET 2: CH-4002 CITY: BASEL STATE: V8 FORMER COMPANY: FORMER CONFORMED NAME: NOVARTIS INC DATE OF NAME CHANGE: 19970114 </SEC-HEADER> <DOCUMENT> <TYPE>SC 13G <SEQUENCE>1 <FILENAME>novartis13g_09282018.htm <TEXT> Document 1 - file: novartis13g_09282018.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>image1.jpg <TEXT> Document 2 - file: image1.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>image2.jpg <TEXT> Document 3 - file: image2.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>image00003.jpg <TEXT> Document 4 - file: image00003.jpg
</DOCUMENT> </SEC-DOCUMENT>